What Is the Best Approach to Reducing Birth Defects Associated with Isotretinoin?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND TO THE DEBATE: Isotretinoin is an effective treatment for severe acne, a condition which can be physically, emotionally, and socially disabling. Because the drug is teratogenic, causing severe birth defects, women taking the drug are directed to avoid pregnancy. In the United States, a series of risk reduction programs have been implemented that aim to prevent pregnant women from taking the drug and to prevent women taking it from getting pregnant. The most recent, and most stringent, is an Internet-based, performance-linked system called iPLEDGE, which tries to ensure that the drug is dispensed only when there is documentary proof that the patient is not pregnant and is using two forms of birth control. Is iPLEDGE the best way to reduce isotretinoin birth defects, or is it an unproven and overly burdensome system?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lammer, E. J., Chen, D. T., Hoar, R. M., Agnish, N. D., Benke, P. J., Braun, J. T., Curry, C. J., Fernhoff, P. M., Grix, A. W., Lott, I. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131401 · Cited by 1,942 · cited 1×
“]—is highly teratogenic. Pregnancies exposed to isotretinoin are at significant risk of serious malformations [”
BackgroundIsotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide
Jick, S. S., Kremers, H. M., & Vasilakis-Scaramozza, C. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.10.1231 · Cited by 277
Isotretinoin therapy for acne: results of a multicenter dose-response study
Strauss, J. S., Rapini, R. P., Shalita, A. R., Konecky, E., Pochi, P. E., Comite, H., & Exner, J. H. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)80100-0 · Cited by 223
Cited by
The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system
Shin, J., Cheetham, T. C., Wong, L., Niu, F., Kass, E., Yoshinaga, M. A., Sorel, M., McCombs, J. S., & Sidney, S. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.09.017 · Cited by 113
Delivery of retinoid-based therapies to target tissues
Moise, A. R., Noy, N., Palczewski, K., & Blaner, W. S. (2007) · Biochemistry · doi:10.1021/bi7003069 · Cited by 93
Compliance with pregnancy prevention measures during isotretinoin therapy
Collins, M.-K., Moreau, J. F., Opel, D., Swan, J., Prevost, N., Hastings, M., Bimla Schwarz, E., & Korb Ferris, L. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.08.034 · Cited by 44
Tsur, L., Kozer, E., & Berkovitch, M. (2008) · Journal of Women's Health · doi:10.1089/jwh.2007.0623 · Cited by 24
Metadata
- Authors
- Abroms, L., Maibach, E., Lyon-Daniel, K., & Feldman, S. R.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2006-11-21
- Volume
- 3
- Issue
- 11
- Pages
- e483
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2038320278
- Cited by
- 62
- References
- 3
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What Is the Best Approach to Reducing Birth Defects Associated with Isotretinoin? https://app.cochat.ai/papers/10.1371/journal.pmed.0030483
- The paper
- Abroms, L., Maibach, E., Lyon-Daniel, K., & Feldman, S. R. (2006). What Is the Best Approach to Reducing Birth Defects Associated with Isotretinoin? PLoS Medicine. https://doi.org/10.1371/journal.pmed.0030483
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.